Selank for PPIs: Anxiety Repair Pathways and Acid Suppression Trade-offs
What's breaking down if you have PPIs (omeprazole, etc.)
The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.
This topic: Selank is studied for anxiety-related pathways without classic benzodiazepine sedation. In the regeneration frame: anxiety can follow tissue stress (gut, sleep, stimulant load); Selank research asks whether stabilizing neurochemistry supports recovery rather than only muting feeling.
Why Selank might help you
- You are reading about PPIs (omeprazole, etc.) — what breaks down matters before any compound name.
- What keeps failing: Chronic stress chemistry, stimulant jitter, non-restorative arousal.
- What Selank is studied to do: Studied for anxiolytic pathways without classic benzodiazepine sedation.
- Therefore for you: If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.
Why PPIs (omeprazole, etc.) matters for you
- Drug: PPIs (omeprazole, etc.)
- What it does: Acid suppression; long-term mucosal and nutrient consequences.
- Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.
How these fit together
Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.
- Selank → anxiety / neurochemistry
What the evidence actually shows
This is a count of what is in this ledger — not a claim about all research worldwide.
- Scientific sources catalogued (PubMed, trials, reviews): 3
- Claims tagged human evidence: 2
- Claims tagged preclinical (animal/lab): 1
- Claims tagged anecdotal: 1
- Reddit posts catalogued: 1
- X posts catalogued: 0
- Other anecdote sources (YouTube, Instagram, etc.): 0
- Total sources in chain: 4
Quantified confidence (this ledger): 0.37 / 1.00 — low–moderate — mostly preclinical
Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.
What scientists say
Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia (source s1)
2008 Russian trial showing comparable anxiolytic efficacy.
Evidence type: Tagged human evidence in this ledger — check sample size and design.
Selank Administration Affects the Expression of Some Genes Involved in GABAergic, Serotonergic and Noradrenergic Neurotransmission (source s2)
Preclinical gene expression data on GABA modulation.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors (source s3)
Review of PPI long-term risks.
Evidence type: Tagged human evidence in this ledger — check sample size and design.
What people say on Reddit
Experiences with Selank — Reddit, r/Anxiety (source s4)
User reports of anxiety reduction.
---
Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.
Evidence ledger 4 · tier-ranked · API
Model review1 contributions · 1 modelExpand the recursive review layer
/api/articles/selank-ppis/contributionsAsk this article · 7 suggested prompts
Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.